Cargando…
Erratum in: Topical Administration of 0.3% Tofacitinib Suppresses M1 Macrophage Polarization and Allograft Corneal Rejection by Blocking STAT1 Activation in the Rat Cornea
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400125/ https://www.ncbi.nlm.nih.gov/pubmed/35976658 http://dx.doi.org/10.1167/tvst.11.8.15 |
Ejemplares similares
-
Topical Administration of 0.3% Tofacitinib Suppresses M1 Macrophage Polarization and Allograft Corneal Rejection by Blocking STAT1 Activation in the Rat Cornea
por: Yu, Jianfeng, et al.
Publicado: (2022) -
Erratum to Tofacitinib
Publicado: (2012) -
Erratum, Vol. 03, October 2006 Release
Publicado: (2013) -
Erratum to: JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016) -
Corneal Allograft Rejection: Immunopathogenesis to Therapeutics
por: Qazi, Yureeda, et al.
Publicado: (2013)